Company Filing History:
Years Active: 2018
Title: Innovative Contributions of A Terrece Pearman in Drug Tracking Technology
Introduction
A Terrece Pearman, an inventive mind located in Riverton, UT, has made significant strides in the realm of medical technology with his innovative patent. His work focuses on enhancing the methods of drug detection through a novel system that promises increased reliability and efficiency.
Latest Patents
Pearman is credited with a patent titled "Drug tracking system including food dyes detectable in bodily waste." This advanced drug tracking system is designed to screen a subject's bodily waste for drug identification. It incorporates drug tags embedded with one or more food dyes that are detectable through photographic or absorption spectroscopic analysis. The system also features a comprehensive database that stores the spectral signatures of each drug tag and associates them with the unique drugs they represent. The innovative approach allows for accurate identification of drugs consumed by analyzing bodily waste samples.
Career Highlights
Currently, A Terrece Pearman is associated with Hall Labs LLC, where he continually contributes to the field of drug tracking technology. His unique patent reflects his dedication to advancing medical research and safety practices in drug monitoring. Pearman's work showcases the intersection of technology and healthcare, aiming to transform how drug consumption is monitored and reported.
Collaborations
At Hall Labs LLC, Pearman collaborates with notable colleagues, including David R. Hall and Steven J. M. Butala. Together, they share a commitment to pioneering developments in their field, further enhancing the capabilities of drug tracking systems and expanding their potential applications in healthcare.
Conclusion
A Terrece Pearman's innovative patent highlights his significant contributions to the medical technology landscape. His drug tracking system stands as a testament to the power of creativity and collaboration in addressing complex healthcare challenges. As technology continues to evolve, Pearman's work may pave the way for enhanced monitoring practices, ultimately fostering safer drug use and improving patient outcomes.